The market is generally quite poor but atleast celadon has some interest. Really do think things are going to pop off here very soon. Think soon as this gets on the radar then its game on.
Trial greenlit for cannabinoid therapy in chronic pain, a UK first, with approvals from NHS, MHRA, and Home Office. Great read titled โCeladon gets nod to start cannabis trial for pain in UK"
Whoa, AstraZeneca's Voydeya FDA green light is cool. This breakthrough in rare disease treatment showcases the power of cutting-edge tech and innovation in healthcare.